目前对膜内球结核病药物治疗的现状
Qin-Dong Jing1,2, Ji-De A3, Lin-Xun Liu1
1Department of General Surgery, Qinghai Provincial People's Hospital, Xining 810000, Qinghai Province, China.
World journal of hepatology
|November 28, 2024
概括
气泡状球结核病 (AE) 治疗面临挑战,目前的药物可以抑制寄生虫的生长,但不能消除它,导致有毒的副作用. 新的疗法,包括合成和天然化合物,显示出更有效的AE治疗的希望.
科学领域:
- 寄生虫学的寄生虫学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 气泡内菌 (AE) 是一种严重的动物性疾病,由 Echinococcus multilocularis引起.
- 高死亡率和迟诊断往往阻止治疗性手术,需要长期的医疗治疗.
- 像阿尔本达这样的当前治疗方法存在局限性,包括不完全根除和显著的药物毒性.
研究的目的:
- 审查近期对膜状球菌的药物治疗的进展.
- 探索新的治疗策略及其作用机制.
- 为未来开发抗AE药物提供见解.
主要方法:
- 关于AE药物治疗的最新研究的文献综述.
- 对新型合成和天然化合物的分析.
- 讨论作用机制,剂量,信号通路和结果.
主要成果:
- 目前的本齐米达类药物主要抑制寄生虫的增殖,并具有有毒副作用.
- 新兴疗法包括抗病毒,抗生素,抗瘤,免疫抑制剂和抗血管原剂.
- 传统医学的天然化合物也显示出治疗潜力.
结论:
- 迫切需要新的AE疗法,以更高的疗效和降低毒性.
- 新型合成和天然化合物为AE药物治疗提供了有前途的途径.
- 对机制和临床结果的进一步研究对于开发改进的抗AE药物至关重要.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Antiepileptic Drugs: Potassium Channel Activators
146
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
146
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
135
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
135
Endocarditis III: Medical Management
2
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
2
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39


